The influence of the alcohol industry on policy, AI Claude for scientists, and more health news from Morning Rounds ...

In her first year of graduate school at Stanford University, back in 2021, Sydney Erickson knew only that she was going to be a physicist. Now Erickson is finishing her doctoral degree and ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

The same family of artificial intelligence that powers today's image generators is now being aimed at one of biology's ...

Together, they form Helios, a new quantum computer built by the British-American company Quantinuum. Quantum computers use ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Although gene therapy has shown promise for the treatment of Duchenne muscular dystrophy (DMD), the limitations of viral vectors have proven challenging to clinical advancement. Now, a new treatment ...

A trio of common amino acids may hold the key to unlocking far more powerful gene therapies. Researchers found that adding them to lipid nanoparticles can boost mRNA delivery up to 20-fold and push ...

Looking ahead to 2030, our model projects MRNA could trade at an average price of $39.90, with a potential range between $29.93 and $49.88. This represents a potential 45.1% decline from today's price ...

Shares of biotechnology company Moderna (NASDAQ:MRNA) jumped 9.1% in the afternoon session after investors positioned ahead of a pivotal FDA advisory committee review for its mRNA seasonal flu vaccine ...

Good afternoon, everyone. Thank you so much for joining us. It's my pleasure to introduce Moderna. And with us, we have Jamey Mock, CFO. Jamey, thanks for joining us. Yes. Great. Well, again, thanks ...